Skip to main content
. 2016 Feb 26;31(2):210–218. doi: 10.3904/kjim.2015.137

Figure 3.

Figure 3.

Development of Janus kinase (JAK) inhibitors. IL, interleukin; IFN, interferon; LIF, leukemia inhibitory factor; OSM, oncostatin M; EPO, erythropoetin; TPO, thrombopoetin; TYK, tyrosine kinase.